Singapore’s superb geographical location, as well as its advanced existing infrastructure, makes the country the ideal place for the pharmaceutical giants. GlaxoSmithKline, Roche and MSD base many of their business activities in Singapore including their supply chain management, medical affairs and regulatory controls. The abundance of skilled talent makes this even more practical.
Of course, Singapore has world-class pharmaceutical manufacturing plants with industry leaders including Pfizer, Novartis and Sanofi all choosing to produce and even launch many of their products in the country. Some of the world’s leading pharmaceutical brands manufacture the active ingredients and biologics drugs substances here. Indeed, eight of the top ten world pharmaceutical companies have operations in Singapore.
The pharmaceuticals industry is one of the fastest evolving in the world with continual changes to development models and regulatory changes. Singapore has an established ecosystem which thrives on this and offers significant value to companies allowing them the opportunity to make the biggest impact within the market sector. Naturally, organisations forge links with leading authorities, institutes as well as clinical research facilities. In fact, the government has pledged S$4 billion in public sector research funding.
The country produces in excess of S$16 billion worth of pharmaceutical products for the global market and employs more than 6,000 skilled workers.